Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) (Middle Region) Peptid
Kurzübersicht für Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) (Middle Region) Peptid (ABIN8110403)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- RARRES3 Peptide - middle region
-
Sequenz
- AGSSSVFSVL SNSAEVKRER LEDVVGGCCY RVNNSLDHEY QPRPVEVIIS
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti- RARRES3 Antibody (ARP74172_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- RARRES3 (Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))
-
Hintergrund
-
Background Information: Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.
Alternative Symbols: RIG1, TIG3, HRSL4, HRASLS4, PLA1/2-3
-
Molekulargewicht
- 17 kDa
-
Gen-ID
- 5920
-
UniProt
- Q9UL19
Target
-
